We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Seeking New COVID-19 Therapeutics, WHO Expands its Solidarity Study to Include Three Licensed Drugs
Seeking New COVID-19 Therapeutics, WHO Expands its Solidarity Study to Include Three Licensed Drugs
Expanding its existing Solidarity trial, the World Health Organization (WHO) will test three additional anti-inflammatory drugs as potential treatments for COVID-19.